arsenic trioxide has been researched along with incb-018424 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadian, S; Ghaffari, SH; Ghavamzadeh, A; Mesbahi, Y; Tabatabaie, PS; Zekri, A | 1 |
1 other study(ies) available for arsenic trioxide and incb-018424
| Article | Year |
|---|---|
Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Cell Line, Tumor; Drug Synergism; G1 Phase Cell Cycle Checkpoints; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Nitriles; Oxidative Stress; Pyrazoles; Pyrimidines; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Signal Transduction; STAT3 Transcription Factor | 2018 |